Assembly of different isoforms of actin and tropomyosin into the skeletal tropomyosin-enriched microfilaments during differentiation of muscle cells in vitro by unknown
Assembly of Different Isoforms of Actin and Tropomyosin into 
the Skeletal Tropomyosin-enriched Microfilaments during Differentiation 
of Muscle Cells In Vitro 
Jim Jung-Ching Lin and Jenny Li-Chun Lin 
Department of  Biology, University of  Iowa, Iowa City, Iowa 52242 
Abstract.  We have used a monoclonal antibody (CL2) 
directed against striated muscle isoforms of tropomyo- 
sin to selectively isolate a class of microfilaments 
(skeletal tropomyosin-enriched microfilaments) from 
differentiating muscle cells.  This class of microfila- 
ments differed from the one (tropomyosin-enriched 
microfilaments) isolated from the same cells by a 
monoclonal antibody (LCK16) recognizing all isoforms 
of muscle and nonmuscle tropomyosin. In myoblasts, 
the skeletal tropomyosin-enriched microfilaments had a 
higher content of a-actin and phosphorylated isoforms 
of tropomyosin as compared with the tropomyosin- 
enriched microfilaments.  Moreover, besides muscle 
isoforms of actin and tropomyosin, significant amounts 
of nonmuscle isoforms of actin and tropomyosin were 
found in the skeletal tropomyosin-enriched microfila- 
ments of myoblasts and myotubes. These results sug- 
gest that different isoforms of actin and tropomyosin 
can assemble into the same set of microfilaments, 
presumably pre-existing microfilaments,  to form the 
skeletal tropomyosin-enriched microfilaments,  which 
will eventually become the thin filaments of myofibrils. 
Therefore,  the skeletal tropomyosin-enriched microfila- 
merits  detected here may represent an intermediate 
class of microfilaments formed during thin filament 
maturation.  Electron microscopic studies of the iso- 
lated microfilaments from myoblasts and myotubes 
showed periodic localization of tropomyosin molecules 
along the microfilaments.  The tropomyosin periodicity 
in the microfilaments of myoblasts and myotubes was 
"35 and 37 nm,  respectively, whereas the nonmuscle 
tropomyosin along chicken embryo fibroblast 
microfilaments had a 34-rim repeat. 
T  ROPOMYOSlN  is an ubiquitous protein associated with 
the  thin  filaments  of  muscle  cells  and  with  the 
microfilaments of nonmuscle cells. In striated muscle, 
tropomyosin together with the troponin complex plays a cen- 
tral  role in  regulating  the Ca÷÷-dependent interaction  be- 
tween actin and myosin (23, 31-33).  Tropomyosin has been 
shown to exist in many isoforms that are specific to cells and 
tissues (19, 21). For example, at least 10 isoforms of tropomyo- 
sin have been identified and purified from chicken materials 
(18, 19). These are the cardiac muscle tropomyosin (36,000 
mol. wt), the fast-migrating  (38,000 mol. wt) and the slow- 
migrating  (45,000 mol. wt) components of gizzard  muscle 
tropomyosin,  the  a-form  (37,500 mol.  wt)  and  13-form 
(40,000 mol.  wt) of skeletal  muscle tropomyosin,  and the 
chicken  embryo fibroblast (CEF) ~ tropomyosin  isoforms  1 
(38,000 mol. wt), 2 (36,500 tool. wt), 3 (32,800 mol. wt), 
a  (45,000  mol.  wt),  and b  (43,000 mol.  wt).  In addition, 
cardiac and skeletal  tropomyosins  also exist in their  phos- 
phorylated forms (26).  It has been shown that different iso- 
1. Abbreviations  used in this paper: CEF, chicken embryo fibroblast; CL2- 
MF, skeletal tropomyosin-enriched microfilaments isolated by CL2 mono- 
clonal antibody; LCK16-MF, tropomyosin-enriched microfilaments isolated 
by LCKI6 rnonoclonal antibody, SFLS,  stress fiber-like structures. 
forms bind to actin filaments with different affinities (6, 10, 
19, 31, 35-37). The functional  difference between these iso- 
forms remains  to be determined. 
The  synthesis  of tropomyosin  isoforms  during  skeletal 
muscle differentiation  has been studied in the in vitro cul- 
tures of primary myogenic cells and clonal cell lines  (4, 8, 
11, 26, 27). It is clear that during myogenesis the expression 
of tropomyosin  isoforms changes  from nonmuscle forms to 
muscle forms, and that the synthesis of  muscle-specific a-ac- 
tin and other muscle proteins increases coordinately.  How- 
ever, two interesting questions remain to be answered.  How 
are the a-actin and skeletal tropomyosin isoforms assembled 
into a set of microfilaments  during  myogenesis,  eventually 
becoming the thin filaments of myofibrils? Do different sets 
of microfilaments coexist in differentiating muscle cells? Our 
approach  to  these questions is  to use different  monoclo- 
nal antibodies  (LCK16 and CL2) against  tropomyosin iso- 
forms to fractionate different classes of microfilaments  from 
differentiating  muscle  cells.  The  fractionation  method  is 
similar to the one we have previously reported (20). The CL2 
antibody has been shown to recognize only tropomyosin iso- 
forms of striated  muscle, whereas the LCK16 antibody ap- 
pears  to  react  with  all  isoforms  of tropomyosin  (17, 18). 
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analysis  of monoclonal  anti- 
body CL2 binding to striated 
muscle  tropomyosins.  Puri- 
fied chicken cardiac tropomy- 
osin (lane 1 ), chicken gizzard 
tropomyosin (lane 2), chicken 
leg muscle tropomyosin (lane 
3),  chicken  breast  muscle 
tropomyosin (lane 5), and to- 
tal extract of chicken embryo 
fibroblasts (lane 4) were sepa- 
rated on SDS polyacrylamide 
gels.  After  electrophoresis, 
proteins  were  transferred  to 
nitrocellulose  papers  and  ei- 
ther stained with Amido black 
(B)  or reacted  with CL2  an- 
tibody (A),  followed by 125I-la- 
beled  goat  anti-mouse  IgG 
(heavy and light chains).  Bound 
antibody  was detected by au- 
toradiography. Monoclonal an- 
tibody CL2 appeared to react 
with  striated  muscle  tropo- 
myosin  but  not  with  gizzard 
tropomyosin  or  CEF  tropo- 
myosin.  However,  in  experi- 
ments  with  heavily  loaded 
CEF extract or purified CEF 
tropomyosin,  we  have  found 
that  the  CL2  antibody  can 
weakly  bind  to  CEF  tropo- 
myosin isoform 3  (18). Num- 
bers on right indicate molecu- 
lar mass  in kilodaltons. 
Based on this specificity, we are now able to use the CL2 an- 
tibody to selectively isolate a  class of skeletal tropomyosin- 
enriched  microfilaments  from  differentiating  muscle  cells. 
By  comparison  and  characterization  of the  microfilaments 
isolated by  either LCK16 or CL2 antibody  from myoblasts 
and myotubes,  we have reached the conclusion that (a) vari- 
ous isoforms of actin and tropomyosin can assemble into the 
same  set  of  skeletal  tropomyosin-enriched  microfilaments 
and  (b)  the  skeletal  tropomyosin-enriched  microfilaments 
obtained here may represent an intermediate in the matura- 
tion of the thin  filaments  of myofibrils. 
Materials and Methods 
Cell Culture 
Primary cultures of CEF were prepared from 10-d-old  embryos as described 
previously  (20). Ceils  were  maintained  in  Dulbecco's  modified  Eagle's 
medium (DME) containing 10 % fetal calf serum. Secondary or tertiary cul- 
tures  of CEF cells were  used  for the  experiments.  Primary  cultures  of 
chicken embryo myogenic ceils were prepared from ll-d-old embryos by a 
modification (18) of the procedure of Konigsberg (15). Normally, ~85-90 % 
of the cells at the next day of culture were myogenic cells that had a slender 
spindle  shape.  Cells  were  maintained  in  DME medium  containing  15% 
horse serum and 2 % chicken embryo extract. On the second day of culture, 
myoblasts started to fuse. After 5-7 d, cultures contained >90%  myotubes. 
Preparation of  Monoclonal Antibodies 
Anti-tropomyosin  monoclonal antibodies LCKI6 and CL2 were prepared 
and characterized as described (17, 18). LCKI6 antibody recognized all iso- 
forms of tropomyosin,  whereas CL2 antibody preferentially reacted with 
tropomyosin isoforms from striated muscle (Fig. 1). It should be noted that 
CL2 antibody could bind weakly to CEF tropomyosin isoform 3 in the case 
of excess amounts of this antigen presented (18). 
Labeling Experiments and Isolation of  Microfilaments 
In the previous study (18), we have shown that CL2 monoclonal antibody 
appeared to be able to immunoprecipitate tropomyosin-enriched microfila- 
ments from  myotubes, but  not  from fibroblasts.  To further  confirm this 
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cells were labeled for 15 h  with [3H]methionine (200 I~Ci; 11.3 Ci/mmol) 
or [35S]methionine  (170 ~tCi,  1340 Ci/mmol), respectively, in methionine- 
free DME medium containing 2.5%  fetal calf serum.  Labeled cells were 
washed and briefly treated with triton/glycerol solution as described (20, 
24). We have previously shown that treatment of cells with Triton/glycerol 
solution is an essential step in the isolation of  microfilaments by monoclonal 
antibodies. This step appears to stabilize the microfilament structure by ex- 
tracting some factors that cause disassembly and/or degradation of micro- 
filaments (24).  An equal  number of counts of Triton/glycerol-insoluble 
residues from CEF and myotubes were mixed together and subjected to 
microfilament isolation with CL2 and LCK16  antibody as described (20, 
24). The microfilaments isolated by this method do not exchange their com- 
ponents with free exogeneous molecules, such as actin and tropomyosin. 
Furthermore, the isolation of microfilaments by this method is affected by 
the biological states of microfilaments in vivo, suggesting that microfila- 
merits isolated by this method may represent those existing in living cells 
(24). The isolated microfilaments were analyzed on two-dimensional gels. 
Protein spots corresponding to actin and tropomyosin isoforms were identi- 
fied and then 3H/35S ratios were determined by cutting spots from the gels 
and counting them in a liquid scintillation counter. 
To analyze the assembly of actin and tropomyosin isoforms into tropo- 
myosin-enriched microfilaments, myoblasts (1-2 d in culture), or myotubes 
(5-7  d  in  culture)  were first labeled  with  [3SS]methionine  as  described 
above and then subjected to the isolation of microfilaments with LCK16 or 
CL2 antibody. The isolated microfilaments were analyzed on both one- and 
two-dimensional gels. Bands or spots corresponding to actin and tropomyo- 
sin isoforms were identified and their radioactivities were quantified as de- 
scribed previously (19, 21). 
One- and Two-dimensional  Gel Electrophoresis 
One-dimensional SDS PAGE was carried out as described by Laemmli (16) 
with a low concentration of bisacrylamide (3). Two-dimensional gel elec- 
trophoresis was performed by a modification (20) of O'Farrelrs procedure 
(28). 
Electron Microscopy 
Small aliquots of isolated mierofilarnents from myoblasts and myotubes 
were applied to carbon-coaled Formvar grids and negatively stained with 
2.5% aqueous uranyl acetate. Samples were then observed in a Philips 300 
electron microscope at an accelerating voltage of 60 kV. The periodicity of 
tropomyosin localization along the isolated microfilaments was measured 
against a stained catalase resolution standard (Polysciences, Inc., Warring- 
ton, PA) with a known periodicity of 8.12 nm. 
Protein Immunobiotting 
Protein immunoblotting was performed as described by Towbin et al. (34). 
Briefly, purified tropomyosin isoforms from chicken leg, breast, and gizzard 
muscle, prepared as described previously (19), and total extract from CEF 
cells were first separaled on SDS polyacrylamide gels and then electropho- 
retically transferred to nitrocellulose papers.  One blot was  stained with 
Figure 2.  Immunofluorescence analysis of striated muscle isoform of tropomyosin in chicken embryo myoblasts and myotubes. Indirect 
immunofluorescence with monoclonal antibody CL2 was performed on myoblast (A and B) and myotube (C and D) cultures.  (A and C) 
Phase-contrast micrographs; (B and D) fluorescent micrographs. There are few negative-stained cells with fibroblastic appearance (arrow- 
heads) in both cultures.  In myoblast cultures,  most mononuclear cells wiih spindle shape are weakly stained (asterisks)  and some fused 
cells show strong staining with CL2  antibody.  At myotube stage,  the striated staining patterns are prominent.  Bar,  10  I~m. 
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in the Microfilaments Isolated by CL2 or LCK16 Antibody 
from the Mixture of  [3H]Methionine-labeled CEF Cells 
and [zsS]Methionine-labeled Myotubes 
(a) Ratio in  (b) Ratio in 
CL2-MF  LCKI6-MF  (a)/(b) 
Total actin  0.56  1.96  0.30 
ct-actin  0.45  1.71 
13-actin  0.65  2.17 
~,-actin  0.54  1.87 
Total TM  0.25  0.93  0.27 
13-TM  0.06  0. l 5 
P13  0.05  0.04 
ct-TM + TM-1  0.30  1.15 
Pet  0.14  0.28 
TM-2  1.67  4.89 
TM-3a  0.28  0.85 
TM-3b  0.38  2.00 
Ratios of actin and tropomyosin isoforms were obtained by quantifying the two- 
dimensional gels of the isolated microfilaments. Tropomyosin  (TM) isoforms 
can be separated into muscle forms (a-TM and 13-TM), phosphorylated muscle 
forms (Pet and P~), and nonmuscle forms (TM-I, TM-2, TM-3a, and TM-3b) 
on two-dimensional gels. However, the spots of ¢t-TM and TM-I are too close 
together on the two-dimensional gel to be quantified separately (19). 
Amido black to detect proteins, and a replicate blot was immunoblotted with 
CL2 antibody as detailed  previously (18). 
Results 
Specificity of  CL2 Monoclonal Antibody: 
Selective Isolation of the Skeletal Tropomyosin- 
enriched Microfilaments 
Hybridoma clone CL2 was previously obtained by the in 
vitro immunization method (18). The antigens recognized by 
this antibody were identified as the striated muscle isoforms 
of tropomyosin by both solid-phase radioimmunoassay and 
protein immunoblotting. As shown in Fig. 1 A, the CL2 anti- 
body reacted with cardiac muscle tropomyosin (lane 1), ~- and 
13-isoforms of leg muscle tropomyosin (lane 3) and breast 
muscle tropomyosin (lane 5), but not with gizzard tropomyo- 
sin  (lane  2)  or  CEF  tropomyosin (lane  4).  Indirect  im- 
munofluorescence  of myoblasts and myotubes with CL2 anti- 
body also supported this specificity. The CL2 antibody did 
not stain fibroblasts in both myoblast and myotube cultures 
(arrowheads in Fig.  2,  B  and D).  Although the antibody 
reacted weakly with mononuclear myoblasts, strong staining 
was observed on all myotubes. 
As reported previously (18), the CL2 antibody was capable 
of immunoprecipitating microfilaments from cultured myo- 
tubes with a yield (estimated by the actin content) similar to 
that of the LCKI6 antibody, which was known to recognize 
all isoforms of tropomyosin. On the other hand, the yields 
of microfilaments isolated from fibroblastic cells by CL2 an- 
tibody were very low (about one-tenth) as compared with 
that obtained by LCK16 antibody (18). These results sug- 
gested that the CL2 antibody could be used to selectively iso- 
late  the  skeletal  tropomyosin-enriched microfilaments but 
not  the  fibroblastic  tropomyosin-enriched microfilaments 
from differentiating muscle cells. 
In  order to determine whether the  CL2  microfilaments 
represent a class of skeletal muscle microfilament, we have 
Table 11. Yield and Tropomyosin/Actin Ratio of Various 
Microfilaments Isolated from Myoblasts, Myotubes, or CEF 
Yield 
Percent of total actin  TM/A* 
Myoblasts 
CL2-MF  8.5  0.19 
LCKI6-MF  9.2  0.17 
Myotubes 
CL2-MF  27.2  0.26-0.29 
LCKI6-MF  25.9  0.26-0.30 
CEF 
LCK16-MF  24.3-32.5,  0.17-0.19, 
The yield of isolated microfilaments was expressed as a percentage of total ac- 
tin in the cells.  Amounts of [3~S]methionine incorporation into the actin band 
of various fractions during microfilament isolation were used for calculation of 
percent. 
* TM/A,  radioactive  ratio  of tropomyosin  to actin.  Values were  calculated 
from [35S]methionine incorporation  into tropomyosin  and actin bands of the 
isolated microfilaments separated on SDS polyacrylamide  gels. 
~; Values obtained  from references  19 and 20. 
used CL2 and LCK16 antibodies to isolate microfilaments 
from a  mixed population of pH]methionine-labeled CEF 
cells and [35S]methionine-labeled myotubes. If the CL2 mi- 
crofilaments  (CL2-MF)  represent  skeletal  tropomyosin- 
enriched microfilaments, the 3H/35S ratio in the CL2-MF 
should  be  lower  than  that  in  the  LCK16  microfilaments 
(LCK16-MF). This type of analysis will also establish the ex- 
tent of background contamination by fibroblastic tropomyo- 
sin-enriched microfilaments in the isolated skeletal tropo- 
myosin-enriched microfilaments. The initial mixture, with 
a  3H/3sS ratio of 0.91,  was subjected to microfilament iso- 
lation  with  either  CL2  or  LCK16  antibody.  The protein 
components of the  isolated microfilaments (CL2-MF and 
LCK16-MF) were resolved on two-dimensional gels. The ra- 
dioactivity of each protein spot was  determined by cutting 
spots from the gels and counting them as described (18). As 
can be seen in Table I, the 3H/35S ratios (a) of protein com- 
ponents in CL2-MF were significantly smaller than that (b) 
in  LCK16-ME  Because both CL2 and  LCK16 antibodies 
immunoprecipitate  roughly  equal  amounts  of 35S-labeled 
microfilaments from myotubes, the (a)/(b) ratios (Table I) of 
total actin and total tropomyosin would represent the extent 
of fibroblastic tropomyosin-enriched  microfilament contami- 
nation  in  skeletal  tropomyosin-enriched  microfilaments. 
Thus,  ,~27-30%  of the  fibroblastic  microfilaments  were 
present as contaminants in the CL2-MF after the microfila- 
ment isolation by CL2 antibody. We have previously shown 
that during microfilament isolation the filaments do not ex- 
change their components with exogeneous molecules, such 
as F-actin (24). This would argue against the possibility that 
the contamination may be due to the recombination occur- 
ring between two types of microfilaments during isolation. 
Assembly of  Actin and Tropomyosin lsoforms into 
the Microfilaments of  Myoblasts and Myotubes 
It has been shown that during muscle differentiation, the ex- 
pression of actin and tropomyosin isoforms changes  from 
nonmuscle forms to muscle forms (4, 8, 11). What is the un- 
derlying mechanism for this transition? Do different sets of 
microfilaments  exist  in  the  differentiating  muscle  cells? 
The Journal of Cell Biology, Volume  103, 1986  2176 Figure  3.  Two-dimensional  gel  analysis  of the  isolated  microfilaments  from chicken  embryo myoblasts and  myotubes.  Coomassie 
Blue-stained  protein patterns of the gels are shown here, with the acidic end to the left. (A and B) Skeletal tropomyosin-enriched microfila- 
ments isolated by CL2 antibody from myoblasts and myotubes, respectively. (C and D) Tropomyosin-enriched microfilaments isolated by 
LCK16 antibody from myoblasts and myotubes, respectively. Hand L indicate the positions of  heavy and light chains of monoclonal antibod- 
ies. Pa and P/] refer to the phosphorylated  forms of skeletal muscle ct-tropomyosin (a-TM) and [3-tropomyosin ([3-TM), respectively. 
These questions are still not completely answered, but our 
ability  to  isolate  skeletal  tropomyosin-enriched  microfila- 
ments by CL2 antibody should provide a  new approach to 
these problems.  Therefore,  we carried out experiments to 
fractionate and characterize myoblast and myotube micro- 
filaments with CL2 and LCK16 antibodies.  Two classes of 
microfilaments,  i.e.,  the  skeletal  tropomyosin-enriched 
(CL2-MF)  and  the  tropomyosin-enriched  (LCK16-MF) 
microfilaments, were obtained. 
Because there did not appear to be a suitable way to esti- 
mate the yield of microfilaments, we determined the amount 
of actin (measured by radioactivity) in various fractions at 
each step of the purification and expressed the yield as a per- 
centage of the total cellular actin.  As seen in Table II, the 
yields for both CL2-MF and LCK16-MF isolated from either 
myoblasts or myotubes are very close (8.5-9.2%  for myo- 
blasts and  25.0-27.2%  for myotubes).  The yield of tropo- 
myosin-enriched  microfilaments  isolated  from  myoblasts 
seems to be relatively low. This may reflect the true amounts 
for myoblast tropomyosin-enriched microfilaments, because 
indirect immunofluorescence microscopy on these cells with 
anti-tropomyosin  antibody  generally  reveals  a  weak  and 
diffuse staining pattern (data not shown).  As cells differen- 
tiated  into  myotubes,  we  readily  obtained  a  comparable 
amount of tropomyosin-enriched microfilaments, as we did 
from CEF cells (Table II). When the tropomyosin/actin ra- 
tios (TM/A in Table II) were calculated from the radioactivi- 
ties  of both  proteins,  a  reasonable  result was  found.  The 
TM/A ratios of tropomyosin-enriched microfilaments from 
myoblasts were similar to that from CEF cells. On the other 
hand, myotube microfilaments contained a higher tropomyo- 
sin/actin  ratio. 
Protein  components of these  two  microfilament classes 
were further analyzed on two-dimensional gels. Fig. 3 shows 
the Coomassie Blue-stained protein profiles of the isolated 
microfilaments. In addition to heavy and light chains of im- 
munoglobulins,  actin  isoforms  (a,  13,  and  ~,)  and  skeletal 
tropomyosin isoforms (ct-TM, 13-TM, Pot, and PI3) were read- 
ily  separated.  As  expected,  the  amounts  of ct-actin  in  the 
microfilaments isolated  from myotubes (Fig.  3,  B  and D) 
Lin and Lin Skeletal Tropomyosin-enriched Microfilaments  2177 Figure 4.  Two-dimensional gel  analysis of the  isolated microfilaments from  [sSS]methionine-labeled  chicken embryo myoblasts and 
myotubes. Fluorographs of the gels are shown here, with the acidic end to the left. (A and B) Skeletal tropomyosin-enriched microfilaments 
isolated by CL2 antibody from myoblasts and myotubes, respectively. (C and D) Tropomyosin-enriched microfilaments isolated by LCK16 
antibody from myoblasts and myotubes, respectively. Pa and P/3, phosphorylated forms of skeletal muscle a-tropomyosin (a-TM) and 
[~-tropomyosin  [3-TM), respectively, v, Vimentin; TN-C, troponin C; 2, 3a, and 3b, CEF tropomyosin isoforms 2, 3a, and 3b, respectively. 
were greatly increased, as compared with those in the myo- 
blast microfilaments (Fig. 3 A and C). There was no obvious 
qualitative difference between CL2-MF and LCK16-MF, ex- 
cept that vimentin and its variants were coprecipitated with 
LCK16-ME  The association of vimentin with LCK16-MF 
appeared to be due to the cross-reaction of LCK16 antibody 
to both tropomyosin and vimentin (17). These same gels were 
further processed for autoradiography. Fig. 4 shows [35S]me- 
thionine-labeled protein profiles of the  isolated  microfila- 
ments. In addition to actin isoforms and skeletal tropomyosin 
isoforms, nonmuscle tropomyosin isoforms 1, 2, 3a, and 3b, 
as identified previously (20), were also synthesized and as- 
sembled into the skeletal tropomyosin-enriched microfila- 
ments (CL2-MF, Fig. 4, A and B) and the tropomyosin-en- 
riched  microfilaments  (LCK16-MF,  Fig.  4,  C  and  D). 
However, the content of these nonmuscle tropomyosin iso- 
forms  in  CL2-MF  was  significantly  lower  than  that  in 
LCK16-ME The radioactive incorporation into each isoform 
of  actin and tropomyosin was measured by cutting spots from 
the gels and counting them. We felt very comfortable in cut- 
ting the spots of actin isoforms, because the well-separated 
spots  could  be  readily  identified  from  the  Coomassie- 
Blue-stained gels. Therefore, the counts of actin did not in- 
clude the long trailing edge on the side of a-actin (Fig. 4). 
However, the a-TM spot was contaminated by nonmuscle 
tropomyosin isoform 1. After normalization with the radio- 
activity of 7-actin or total actin, relative rates of [35S]methi- 
onine  incorporation  into  actin  and  tropomyosin isoforms 
from the isolated microfilaments were obtained and summa- 
rized in Table III. 
As seen in Table HI A, the skeletal tropomyosin-enriched 
microfilaments (CL2-MF) isolated from both myoblasts and 
myotubes contained higher relative amounts of a-actin than 
the respective tropomyosin-enriched  microfilaments (LCK16- 
MF). Furthermore, the relative proportions of actin isoforms 
remained very similar in the CL2-MF of myoblasts and myo- 
tubes (Table In A, columns a and c), except a significant in- 
crease in the assembly of a-actin onto the myotube microfila- 
ments. Judging from the Coomassie-Blue-stained gels (Fig. 
3, A and B), the chemical amounts of a-actin in the myotube 
CL2-MF were much higher than that in the myoblast microfil- 
aments. These results suggested that the coassembly of new- 
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Isolated by CL2 Antibody or LCK16 Antibody from Cultured Chicken Embryo Myoblasts and Myotubes 
Myoblasts  Myotubes 
CL2-MF (a)  LCK16-MF (b)  a/b  CL2-MF (c)  LCK16-MF (d)  c/d 
a-Actin  1.26  0.81  1.55  1.39  1.06  1.31 
l~-Actin  2.19  1.99  1.10  2.28  1.86  1.22 
T-Actin  1.00  1.00  1.00  1.00  1.00  1.00 
Total actin  100 (7,876)  100 (8,564)  100 (19,030)  100 (18,195) 
[3-TM  3.46  2.52  1.37  8.67  8.16  1.06 
*P[3  1.50  0.33  4.55  1.94  1.87  1.04 
a-TM +  TM-1  9.53  8.73  1.09  10.12  10.61  0.95 
Pa  2.62  0.93  2.82  3.07  2.69  1.14 
TM-2  0.84  1.45  0.58  1.26  1.79  0.70 
TM-3a  1.21  2.10  0.58  0.47  0.74  0.64 
TM-3b  0.28  0.56  0.50  0.21  0.33  0.64 
Note that the spots of ¢t-TM and TM-1 are too close together on the two-dimensional  gel to be quantified separately  (19).  Numbers in the parenthesis are the 
counts (cpm) of total actin (a,  13, and y) in different microfilament  preparations. 
*PI3, Phosphorylated  isoform of 13-tropomyosin (~-TM);  Pet,  phosphorylated  isoform of et-tropomyosin  (a-TM);  TM-1,  TM-2,  TM-3a,  and  TM-3b,  CEF 
tropomyosin isoforms 1, 2, 3a,  and 3b, respectively. 
ly  synthesized actin  isoforms into  pre-existing  microfila- 
ments  and  that  the  pre-existing  microfilaments  could  be 
enriched in 13-actin amount, as in the case of myoblast CL2- 
MF (Fig. 3 A) or in ¢t-actin amount, as in the case of  myotube 
CL2-MF (Fig.  3 B). 
In Table III B, the ratio of each tropomyosin isoform was 
expressed per  100 parts of total actin counts in the micro- 
filaments.  It was  clear that  skeletal tropomyosin-enriched 
(CL2-MF) and tropomyosin-enriched (LCK16-MF) micro- 
filaments  from  myoblasts  had  different  compositions  of 
tropomyosin isoforms. The spots for muscle isoform a-TM 
and nonmuscle isoform 1 of tropomyosin were too close to- 
gether on the two-dimensional gel to be quantified separate- 
ly. Therefore, we always treated them as a unit. However, one 
should keep in mind that in the differentiating muscle cells, 
the tt-TM is predominant to the nonmuscle tropomyosin iso- 
form 1.  The content (Table HI B, column a) of nonmuscle 
tropomyosin isoforms (TM-2, TM-3a, and TM-3b) in the 
myoblast CL2-MF was less than that (Table III B, column 
b) in the LCK16-MF of the same cells. However, the CL2- 
MF still contained •50-58%  (column a/b) of the nomnuscle 
tropomyosin isoforms  found  in  LCK16-ME  These  ratios 
(50-58%) were greater than the calculated contamination 
(27-30%) during isolation, as described above. This com- 
parison appears to be reasonably valid, since the tropomyo- 
sin/actin ratios for myoblast and fibroblast microfilaments 
and  the  total  amounts  of actin  precipitated  by  CL2  and 
LCK16 antibodies are very similar (Table II). Therefore, the 
nonmuscle tropomyosin isoforms were a significant compo- 
nent of the skeletal tropomyosin-enriched microfilaments of 
myoblasts.  As  muscle  cells  differentiated into  myotubes, 
tropomyosin isoform contents of the CL2-MF and LCK16- 
MF became very similar except for nonmuscle isoforms. 
Again, a significant amount of nonmuscle tropomyosin iso- 
forms was associated with the skeletal tropomyosin-enriched 
microfilaments of myotubes. 
When one compared the changes in tropomyosin isoforms 
within the CL2-MF during development (Table III B,  col- 
umns a and c), the increases in muscle a- and I~-TM and the 
decreases in nonmuscle TM-3a and 3b were evident. How- 
ever, an unexpected increase in nomnuscle TM-2 isoform 
from myoblasts to myotubes was  repeatedly obtained.  At 
present there is no reasonable explanation for this increase. 
In myoblasts, a striking difference between the tropomyo- 
sin  content of CL2-MF  and  LCK16-MF was  the  relative 
amount of phosphorylated forms (Pet and PI3 in Table III B) 
of muscle tropomyosin. The skeletal tropomyosin-enriched 
microfilaments (CL2-MF) contained 4.5- and 2.8-fold high- 
er concentrations of the  phosphorylated forms of 13- and 
a-tropomyosins, respectively, than the tropomyosin-enriched 
microfilaments of myoblasts (LCK16-MF). This difference 
appeared to diminish as the muscle cells differentiated into 
myotubes. In another experiment with myoblasts pulse-la- 
beled for 4 h, we also obtained a higher content of the phos- 
phorylated forms of muscle tropomyosin in the skeletal tro- 
pomyosin-enriched microfilaments (data  not shown).  The 
physiological significance of this finding remains to be deter- 
mined. 
It should be noted that the chemical amount (estimated by 
the Coomassie Blue staining intensity) of the phosphorylated 
form of a-tropomyosin was  greater than the unphosphory- 
lated form in myotube microfilaments (Fig.  3,  B  and D), 
whereas  the  reverse  relation  was  found  in  the  myoblast 
microfilaments (Fig. 3, A and C).  However, the rate of as- 
sembly ([35S]methionine  incorporation) of the phosphory- 
lated form of tt-tropomyosin into myotube microfilaments 
was much lower than that of  the unphosphorylated form (Fig. 
4, B and D,  Table III B). 
Electron Microscopic Characterization  of  Isolated 
Microfilaments from Myoblasts and Myotubes 
When the isolated microfilaments from myoblasts and myo- 
tubes were negatively stained and observed with the electron 
microscope, ordered bundles of microfilaments formed by 
anti-tropomyosin monoclonal antibodies can be readily seen 
(Fig.  5).  In addition, cross-striations along whole bundles 
are apparent. These cross-striations represent the location of 
antibodies, which in turn indicate the position of tropomyo- 
sin molecules. The periodicity may further reflect the size of 
the tropomyosin rod, assuming every tropomyosin dimer ly- 
ing in the grooves of actin filaments does not overlap. As can 
Lin and Lin Skeletal Tropomyosin-enriched Microfilaments  2179 Figure 5.  Electron micrographs of isolated microfilaments from chicken embryo myoblasts (A and B) and myotubes (C-F). (A, C, and 
E) Tropomyosin-enriched  microfilaments isolated by LCK16  antibody, which recognized all isoforms of  tropomyosin. (B, D, and F) Skeletal 
tropomyosin-enriched microfilaments isolated by CL2 antibody. The isolated microfilaments were negatively stained with uranyl acetate 
and observed with an electron microscope. Arrowheads indicate the localization of tropomyosin molecules visualized by the binding of 
anti-tropomyosin monoclonal antibody. Bar, 0.1  Ima. 
be  seen in Fig.  5,  both CL2-MF and LCK16-MF isolated 
from myotubes usually have more ordered bundles and more 
obvious periodicity than  the  microfilaments isolated  from 
myoblasts.  An increase in the tropomyosin/actin ratio (Ta- 
ble II) may explain this observation. 
To measure the tropomyosin  periodicities in both CL2-MF 
and LCK16-MF of myoblasts and myotubes, we have used a 
catalase standard with a periodicity of 8.12 nm for calcula- 
tion. Measurements were always made on bundles that con- 
tain  between  5  and  10 continuous cross-striations.  Histo- 
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Figure 6. Histogram of  the measurements of tropomyosin periodici- 
ties along the isolated microfilaments from myoblasts (A and B) and 
myotubes (C and D).  (A and  C) Skeletal tropomyosin-enriched 
microfilaments isolated by CL2 antibody. (B and D) Tropomyosin- 
enriched microfilaments isolated by LCK16 antibody. The isolated 
microfilaments were negatively stained and observed with an elec- 
tron microscope. For measurement, a stained catalase resolution 
standard with a periodicity of 8.12 nm was used to calibrate the 
tropomyosin periodicity. Each measurement of tropomyosin perio- 
dicity was made from a bundle that contained 5-10 cross-striations 
visualized by the binding of monoclonal antibody. 
grams from such measurements are shown in Fig. 6, and the 
mean values  of tropomyosin periodicities along  CL2-MF 
and LCK16-MF of myoblasts and myotubes are summarized 
in Table IV. No significant difference between the tropomyo- 
sin periodicities of skeletal tropomyosin-enriched microfila- 
ments (CL2-MF) and tropomyosin-enriched microfilaments 
(LCK16-MF) could be detected. However, the tropomyosin 
periodicity (37 nm) along myotube microfilaments was con- 
siderably longer (P < 0.001) than those of myoblast microfila- 
ments (35 nm) or CEF microfilaments (34 nm). Early studies 
on tropomyosin paracrystals have shown that the repeat dis- 
tance (38-40 nm) in the paracrystals obtained from muscle 
tropomyosin is consistently longer than that obtained from 
nonmuscle tropomyosin (5,  7,  10,  30).  These observations 
may imply that the nonmuscle tropomyosin is shorter than 
muscle tropomyosin. 
Discussion 
In  the  present  study,  a  striated  muscle  tropomyosin iso- 
form-specific monoclonal antibody (CL2) was  used to se- 
lectively  isolate  a  class  of microfilaments,  i.e.,  skeletal 
tropomyosin-enriched microfilaments (CL2-MF), from dif- 
ferentiating muscle cells. CL2-MF differ from another class 
of  microfilaments,  i.e.,  tropomyosin-enriched  microfila- 
ments  (LCK16-MF),  isolated  from  the  same  cells  by  a 
monoclonal  antibody  (LCK16)  against  all  isoforms  of 
tropomyosin. 
Since the experimental approach used in this study (see 
also references 20 and 24) allows us to directly isolate the 
skeletal tropomyosin-enriched microfilaments, the relative 
ratios of [35S]methionine  incorporation should partly reflect 
the relative ratios of assembly into microfilament fractions. 
The assembly of tt-actin appears to be lower than that of 
Table IV. Periodicity of Tropomyosin Binding to 
Microfilaments Isolated from Chicken Embryo Myoblasts 
and Myotubes by CL2 or LCK16 Monoclonal Antibody 
Periodicity value (mean ___ SD) 
CL2-MF  LCK 16-MF 
Myoblasts  35.2 a  -I-  2.0  (n  =  46)*  35.3 ~ +  2.2  (n  =  37) 
Myotubes  37.4 b  -t-  1.6  (n  =  85)  36.8  d  +  1.8  (n  =  66) 
CEF  -  33.9  +  2.1  (n  =  11) 
Using the two-sample t test for means between a and b (P < 0.001, equal stan- 
dard deviations) or between c and d (P <  0.001, unequal standard deviations), 
it is clear that the difference in tropomyosin periodicity between myoblasts and 
myotubes is significant. 
* n,  Number of bundles measured that contained 5-10 cross-striations. 
13-actin in both myoblast and myotube CL2-MF (Table III A). 
However, the increase in the assembly of a-actin from myo- 
blasts to myotubes is significantly greater than that in 13-actin 
or y-actin (Table III A, columns a and c). Therefore, the total 
amounts (estimated from Coomassie Blue-stained gels) of 
a-actin  accumulated  in  myotube  microfilaments  can  be 
greater than 13-actin or y-actin (Fig. 3 B). Another possible 
reason for the preferential accumulation of ct-actin  in myo- 
tube microfilament may be due to a slower turnover rate for 
a-actin as compared with 13-actin or ~/-actin.  More pulse- 
chase experiments are needed to test this possibility. 
The skeletal tropomyosin-enriched microfilaments reported 
here contained not only muscle isoforms of actin and tropo- 
myosin but also their nonmuscle counterparts. The amounts 
of nonmuscle isoforms associated with this class of micro- 
filament could not be totally accounted for by contamination 
with the fibroblastic microfilaments during isolation (Tables 
I-III) or by contamination of fibroblasts in the culture we 
used.  This finding suggests that different isoforms of actin 
and tropomyosin can be assembled into the same set of skele- 
tal tropomyosin-enriched microfilaments. 
An early study on the development of myofibrils by elec- 
tron microscopy has demonstrated that new sarcomeres ap- 
peared to form on a pre-existing bundle of thin filaments, 
suggesting that the microfilament bundles may be precursors 
to myofibrils (29). From studies of temporal and topographi- 
cal relationships between stress fiber-like structures (SFLS) 
and nascent myofibrils in both ethyl methanesulfonate-re- 
covering skeletal myosheets and normal cultured heart cells, 
Holtzer and his colleagues have further shown that at the 
earliest stage of myofibrillogenesis, individual nascent myo- 
fibrils appear to be part of or juxtaposed to pre-existing in- 
dividual SFLS and that at the later stages all SFLS have dis- 
appeared and are replaced with mature myofibrils (1, 9, 14). 
Although  a  transient  one-on-one relationship between in- 
dividual SFLS and newly emerging individual nascent myo- 
fibrils has been suggested and proposed, these investigators 
could  not  determine  whether  the  earliest  muscle-specific 
myofibrillar proteins  form transitory heteropolymers with 
the nonmuscle isoforms or homopolymers of thick and thin 
filaments in the vicinity of the pre-existing SFLS. In the pres- 
ent biochemical study, we have demonstrated that the skele- 
tal  tropomyosin-enriched microfilaments contain  not only 
muscle isoforms but also nonmuscle isoforms of actin and 
tropomyosin, suggesting that they can assemble into hetero- 
polymers. This result supports the idea that there is a gradual 
transition of one set of microfilaments into another during 
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of actin into stress fiber of fibroblasts has also been demon- 
strated by microinjection of purified muscle a-actin (12) or 
by transfection of a-actin gene sequence (13) into live cells. 
The myoblast CL2-MF are enriched not only in a-actin 
content but also in the phosphorylated isoforms of skeletal 
~t- and ~-tropomyosins when compared with the myoblast 
LCK16-ME The difference in phosphorylated form content 
cannot be due to the possibility that the LCK16 antibody used 
in the isolation of microfilaments contains higher phospha- 
tase activity than the CL2 antibody, because both CL2-MF 
and LCK16-MF isolated from myotubes contain a  similar 
amount of these phosphorylated isoforms.  At the present 
time,  the physiological significance of tropomyosin phos- 
phorylation is not known. Mak et al.  (22) have speculated 
that the phosphate group of serine-283 on one molecule of 
tropomyosin could form a salt linkage with lysine-6 on the 
other molecule. This linkage could participate in stabilizing 
the head-to-tail overlap of the tropomyosin dimers that are 
believed to mediate a degree of cooperation in the control 
of muscle contraction (25,  32).  However,  Barany et al. (2) 
have demonstrated that phosphorylation of tropomyosin is 
independent of muscle contraction in frogs. 
In the present work, we have consistently found a higher 
content of phosphorylated isoforms of tropomyosin in the 
skeletal tropomyosin-enriched microfilaments of myoblasts. 
This suggests that during muscle differentiation in vitro, the 
conversion of microfilaments (which initially contain either 
nonmuscle forms of tropomyosin or no tropomyosin) into 
skeletal tropomyosin-enriched microfilaments is accompa- 
nied by phosphorylation of muscle tropomyosin. Whether 
this phosphorylation occurs before or after the assembly of 
muscle isoforms in microfilaments remains unclear. As can 
be seen in Figs. 3 and 4, myotube CL2-MF contains a higher 
chemical amount of the phosphorylated form of ~t-tropomyo- 
sin and less  [35S]methionine  incorporation into this phos- 
phorylated form as  compared with the unphosphorylated 
form. This result may be explained by a slower turnover rate 
of the phosphorylated form of a-tropomyosin. However,  it 
may also suggest that phosphorylation, at least of ~t-tropo- 
myosin, occurs after assembly into microfilaments. Further 
experiments  with pulse-chase  labeling  may establish this 
precursor-product relationship. Although the function of the 
phosphorylated form of tropomyosin remains unclear, it is 
possible that the phosphorylated isoforms of tropomyosin in 
the skeletal tropomyosin-enriched microfilaments may serve 
as a label or marker on microfilaments to allow further as- 
sembly of muscle-specific isoforms of actin and tropomyo- 
sin. The phosphorylated isoforms of tropomyosin have been 
shown to be the major forms of tropomyosin in the leg mus- 
cle of 10-d-old embryos (27). These phosphorylated isoforms 
found in embryonic muscle may also play a marking function 
in the maturation of thin filaments. During embryonic devel- 
opment,  the  amount of phosphorylated isoforms of both 
~t-  and  fl-tropomyosins decreases  so  that  after  hatching 
<20%  of each isoform is phosphorylated. 
What molecular mechanism can account for the transition 
from nonmuscle to muscle forms of actin and tropomyosin 
during  myogenesis? A  pre-existing  microfilament,  either 
with nonmuscle tropomyosin or devoid of tropomyosin, may 
serve as a precursor for the assembly of muscle actin and 
tropomyosin.  We  and other  investigators have  previously 
shown that nonmuscle tropomyosins have lower binding af- 
finity for actin filaments than do muscle tropomyosins (6, 10, 
19).  Thus,  competition  between  muscle  and  nonmuscle 
tropomyosins for binding to microfilaments may well be a 
part of the transition mechanism. Moreover, the phosphory- 
lation of muscle tropomyosins may amplify this competition, 
presumably by enhancing the head-to-tail polymerization of 
tropomyosin dimers. Once enough molecules of muscle tro- 
pomyosins are assembled, the microfilaments can become 
the skeletal tropomyosin-enriched microfilament, as defined 
by the CL2 antibody. In addition to being rich in ~t-actin con- 
tent, the skeletal tropomyosin-enriched microfilament con- 
tains a higher content of phosphorylated forms of muscle 
tropomyosin. These phosphorylated isoforms may serve as 
a  marker on the skeletal tropomyosin-enriched microfila- 
ment for further assembly of muscle actin, tropomyosin, and 
other thin filament proteins to eventually form mature thin 
filaments  of myofibrils.  However,  more  experiments  are 
needed to test this hypothesis. 
It is now known that nonmuscle tropomyosin is shorter 
than muscle tropomyosin (Table IV, references 5, 7, 10, 30). 
Thus,  we  should expect  to  have a  larger  periodicity for 
tropomyosin in the myoblast CL2-MF as opposed to that in 
the myoblast LCK16-ME The fact that we do not detect any 
difference is totally surprising. A possible explanation is that 
tropomyosin dimer in myoblast microfilaments may organize 
differently. For example,  they may have more  region for 
head-to-tail overlap as compared with that in myotube micro- 
filaments. 
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